HilleVax Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-123.57	-159.81	-102.41	-2.1
Depreciation & Amortization	2.16	1.15	0	0
Share-Based Compensation	13.59	3	0.07	0
Other Operating Activities	21.04	93.67	95.04	0.83
Operating Cash Flow	-86.78	-61.99	-7.3	-1.27
Capital Expenditures	-10.75	-4.01	-0.05	0
Change in Investments	-83.89	0	0	0
Other Investing Activities	-	-2.5	-2.76	-
Investing Cash Flow	-94.64	-6.51	-2.81	0
Share Issuance / Repurchase	108.9	210.3	-0.79	0
Debt Issued / Paid	9.8	14.67	135	1.33
Financing Cash Flow	118.7	224.97	134.21	1.33
Net Cash Flow	-62.72	156.47	124.11	0.05
Free Cash Flow	-97.53	-66	-7.34	-1.27
Free Cash Flow Per Share	-2.40	-2.43	-1.31	-0.29

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).